Company: GEHC
Filing Date: 2025-04-30
Form Type: 10-Q
Source: 0001932393-25-000014
Chunk: 23

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-30
Form: 10-Q
Item: Item 8
Chunk 23
---
Asset write-downs1 7 Total restructuring activities – net$22 $40 These restructuring initiatives are expected to result in additional expenses of approximately $40 million, to be incurred primarily over the next 12 months, substantially related to employee-related termination benefits and asset write-downs. Restructuring expenses (gains) are recognized within Cost of products, Cost of services, or SG&A, as appropriate, in the Condensed Consolidated Statements of Income.

22

Table of Contents                 

Liabilities related to restructuring are recognized within Current compensation and benefits, All other current liabilities, Non-current compensation and benefits, and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position. The activity related to our restructuring liabilities follows.Employee termination costsFacility and other exit costsTotalBalance at December 31, 2024$67 $18 $86 Charges19 1 20 Payments and other adjustments(14)(3)(17)Balance at March 31, 2025$73 $16 $89 

NOTE 15. EARNINGS PER SHARE

The numerator for both basic and diluted earnings per share (“EPS”) is Net income attributable to GE HealthCare. The denominator of basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, restricted stock units, and performance share units is reflected in the denominator for diluted EPS using the treasury stock method.Earnings Per ShareFor the three months ended March 31(In millions, except per share amounts)20252024Numerator:Net income$588 $388 Net (income) loss attributable to noncontrolling interests(24)(14)Net income attributable to GE HealthCare564 374 Denominator:Basic weighted-average shares outstanding457 456 Dilutive effect of common stock equivalents2 3 Diluted weighted-average shares outstanding459 459 Basic earnings per share$1.23 $0.82 Diluted earnings per share1.23 0.81 Antidilutive securities(1)2 4 (1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.

NOTE 16. SUPPLEMENTAL FINANCIAL INFORMATION

CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.As ofMarch 31, 2025December 31, 2024Cash and cash